Achieve Life Sciences
ACHV
72 hedge funds and large institutions have $38.4M invested in Achieve Life Sciences in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 6 closing their positions.
540% more call options, than puts
Call options by funds: $32K | Put options by funds: $5K
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
3% more funds holding
Funds holding: 70 → 72 (+2)
9% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 22
6.04% less ownership
Funds ownership: 47.52% → 41.48% (-6%)
33% less capital invested
Capital invested by funds: $57.5M → $38.4M (-$19.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
+$838K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$762K |
| 3 |
SC
Shay Capital
New York
|
+$749K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$181K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$177K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$4.6M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$4.33M |
| 3 |
DI
DUMAC Inc
Durham,
North Carolina
|
-$176K |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
-$146K |
| 5 |
Goldman Sachs
New York
|
-$127K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Squarepoint
New York
| – | -$61.7K | -17,519 | Closed |
|
77
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$47.5K | -13,498 | Closed |
|
|
EWA
78
EverSource Wealth Advisors
Birmingham,
Alabama
| – | -$92 | -26 | Closed |
|
ACHV Hedge Fund Activity: Q1 2025 in Review
72 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2025, worth a combined $38.4M — down 33% from $57.5M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ACHV positions and 6 closed out — a net gain of 2 holders — while 20 added to existing stakes and 22 trimmed.
The largest buyer was J. Goldman & Co, adding an estimated $838K. The largest seller was Sofinnova Investments, exiting entirely with an estimated $4.6M sold.
- 72 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2025, up from 70 in Q4 2024.
- Funds reported $38.4M of Achieve Life Sciences stock for Q1 2025, down 33% quarter-over-quarter.
- 8 funds opened new Achieve Life Sciences positions in Q1 2025 and 6 closed out, a net change of +2 holders.
- The largest Achieve Life Sciences buyer in Q1 2025 was J. Goldman & Co, an estimated $838K added.
- The largest Achieve Life Sciences seller in Q1 2025 was Sofinnova Investments, an estimated $4.6M sold.
Based on aggregated 13F filings for Q1 2025.